GoodTCells
- Biotech or pharma, therapeutic R&D
Good T Cells, Inc. is an immuno-therapeutic company focused on harnessing the following:
1. Discovery of: (a) first-in-class surface protein associated with immunological and metabolic diseases, as well as neurodegenerative disorders. (b) first-in-class secreted protein linked to lung and liver fibrosis. (3) first-in-class cytoplasmic protein connected to liver fibrosis and obesity.
2. In vitro and in vivo functional characterization of three novel target proteins in animal models of autoimmune diseases, obesity, Alzheimer's disease, and fibrosis.
3. Development of innovative therapeutics for autoimmune diseases, metabolic conditions (such as obesity), neurodegenerative disorders, and lung and liver fibrosis through peripheral immune modulation.
Address
SeoulSouth Korea
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}